Plus   Neg

Barratt Developments Says Trading Strong; FY View In Line With Board's Outlook

UK home builder Barratt Developments Plc. (BDEV.L), in its trading update for the period from January 1 to May 6, said its trading is strong and the outlook for the full year remains in line with the Board's expectations.

Sales rate is in line with the prior year at 0.80 net private reservations per active outlet per average week.

Total forward sales, including Jvs, was up 2.5% as at May 6 to 3.29 billion pounds.

The company said it expects to approve the purchase of more than 20,000 plots for the full year to help support future volume growth, compared to last year's 18,497 plots.

David Thomas, Chief Executive, said, "Trading since the beginning of the year has been strong across the country driven by good customer demand for our high quality new homes and an attractive lending environment. We have a healthy forward order book and a robust balance sheet.... we continue to focus on growing our housing output, creating jobs and supporting economic growth across the country."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT